PMID- 20204065
OWN - NLM
STAT- PubMed-not-MEDLINE
DCOM- 20110714
LR  - 20200929
IS  - 1687-9635 (Electronic)
IS  - 1687-9627 (Print)
VI  - 2009
DP  - 2009
TI  - Hypersensitivity vasculitis with leukocytoclastic vasculitis associated with 
      alpha-1-proteinase inhibitor.
PG  - 941258
LID - 10.1155/2009/941258 [doi]
LID - 941258
AB  - Prolastin is a commercially available form of alpha-1-antitrypsin (AAT) that is 
      derived from pooled human plasma and used for treatment of severe 
      alpha-1-antitrypsin deficiency (AATD). We describe a patient with AATD who 
      developed presumed hypersensitivity vasculitis (HV) following a Prolastin 
      infusion. Hypersensitivity vasculitis (HV), or cutaneous vasculitis, is 
      characterized by inflammation of the small vessels of the skin with resultant 
      ischemia to the distally supplied areas. To our knowledge, this is the first 
      reported case of presumed hypersensitivity vasculitis following Prolastin 
      infusion.
FAU - Mwirigi, Nicola W
AU  - Mwirigi NW
AD  - Thoracic Diseases Research Unit, Division of Pulmonary, Critical Care and 
      Internal Medicine, Department of Medicine, Mayo Clinic College of Medicine, 
      Rochester, MN 55905, USA.
FAU - Thomas, Charles F
AU  - Thomas CF
LA  - eng
PT  - Case Reports
DEP - 20100224
PL  - United States
TA  - Case Rep Med
JT  - Case reports in medicine
JID - 101512910
PMC - PMC2829622
EDAT- 2009/01/01 00:00
MHDA- 2009/01/01 00:01
PMCR- 2010/02/24
CRDT- 2010/03/06 06:00
PHST- 2009/10/18 00:00 [received]
PHST- 2009/11/18 00:00 [accepted]
PHST- 2010/03/06 06:00 [entrez]
PHST- 2009/01/01 00:00 [pubmed]
PHST- 2009/01/01 00:01 [medline]
PHST- 2010/02/24 00:00 [pmc-release]
AID - 10.1155/2009/941258 [doi]
PST - ppublish
SO  - Case Rep Med. 2009;2009:941258. doi: 10.1155/2009/941258. Epub 2010 Feb 24.